In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Overview Layer-3 blockchains are emerging as the next evolution in scaling beyond Layer-2, offering custom environments for ...

When security vulnerabilities appear in popular frameworks, they can affect thousands of websites overnight. That’s exactly what’s happening with a newly discovered vulnerability in Next.js – one of ...

Summary In this episode of The Defenders Log, Paul Mockapetris, the architect of DNS, discusses the evolving role of the Domain Name System from a simple directory to a sophisticated security tool. He ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

Melodramatic twists and turns are part of the appeal of soap operas, but some of the stars of "Days of Our Lives" have faced down some real-life downfalls and tragedies, too. Donald Trump gives update ...

The work is finally done for the worst selection committee in the College Football Playoff’s dozen-year history, and there are only two ways to explain the grotesque, odious bracket that it belched ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...